Psychotic Disorders - Finland

  • Finland
  • Revenue in the Psychotic Disorders market is projected to reach US$23.46m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.94%, resulting in a market volume of US$24.35m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$2,257.00m in 2024).
  • In relation to total population figures, per person revenues of US$332.90 are generated in 2024.

Key regions: Germany, France, United States, Australia, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Psychotic Disorders market in Finland is experiencing significant growth and development.

Customer preferences:
One of the main factors driving the growth of the Psychotic Disorders market in Finland is the increasing awareness and understanding of mental health issues among the general population. This has led to a growing demand for effective treatments and therapies for psychotic disorders. Additionally, there is a growing acceptance and recognition of the importance of mental health in society, which has further fueled the demand for treatments.

Trends in the market:
One of the key trends in the Psychotic Disorders market in Finland is the shift towards personalized medicine. Advances in genetic research and technology have allowed for a better understanding of the genetic factors that contribute to psychotic disorders. This has led to the development of targeted therapies that are tailored to the individual patient's genetic profile. This trend towards personalized medicine is expected to continue driving the growth of the market in the coming years.Another trend in the market is the increasing use of digital health technologies. Mobile applications and online platforms have emerged as valuable tools in the management and treatment of psychotic disorders. These technologies provide patients with access to resources, support, and self-help tools, which can help improve their overall well-being and quality of life. The use of digital health technologies is expected to continue growing as more patients and healthcare providers recognize their benefits.

Local special circumstances:
Finland has a well-developed healthcare system that provides comprehensive coverage for mental health services. This has contributed to the accessibility and availability of treatments for psychotic disorders in the country. Additionally, Finland has a strong focus on research and innovation in the healthcare sector, which has led to the development of new and more effective treatments for psychotic disorders.

Underlying macroeconomic factors:
Finland has a stable economy with a high standard of living. This provides individuals with the financial means to seek and afford treatments for psychotic disorders. Additionally, the government has implemented policies and initiatives to support mental health services and improve access to care. These factors have created a favorable environment for the growth of the Psychotic Disorders market in Finland.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)